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Abstract
Neurotrophic factors are proteins that play an important role in the development and
maintenance of neurons. Recent studies have shown that neurotrophic factors may hold promise
for treating damage to the nervous system caused by trauma or diseases, such as amyotrophic
lateral sclerosis or Parkinson’s disease. Glial cell line-derived neurotrophic factor (GDNF) is
expressed in skeletal muscles and affects peripheral motor neurons. Results of previous studies
have demonstrated that exercise can increase GDNF content in skeletal muscle of rat. The goal of
the current study was to examine whether expression of GDNF in skeletal muscle of mouse is also
regulated by physical activity. Our hypothesis states that muscles undergoing higher levels of
contractile activity will express GDNF at higher levels than muscle exhibiting lower levels of
contractile activity. For these studies we examined GDNF protein content in tissues from
sedentary control mice and in mice following exercise. Muscles examined included the diaphragm
(DIA), an involuntary slow twitch muscle and pectoralis major (PEC), a voluntary slow twitch
muscle. Treatment groups included 7 control mice and 6 mice that underwent walk training. The
treatment group had a one-week training period, and then exercised for 30 minutes a day, at 8
meters/minute, five days a week. Following completion of the exercise regimen muscles were
removed and processed for determination of GDNF protein content using enzyme-linked
immunosorbant assay, GDNF protein localization and end plate morphology. The results show
that DIA from control animals contains more GDNF than PEC, while exercise increased GDNF
protein content in PEC but not DIA. These findings suggest that GDNF production is effected by
exercise in voluntary slow-twitch muscles, but not involuntary slow-twitch muscles. These results
contribute to understanding the mechanisms underlying the normal control of GDNF expression in
skeletal muscles. It is important to develop a more complete understanding of normal expression
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of GDNF in skeletal muscle before we can determine whether GDNF-based therapies may be used
in the treatment of traumatized or diseased neural tissues.
This work was supported by a grant from the Faculty Research and Creative Activities Award,
Western Michigan University, NIH grant 1 R15 AG022908-01A2, NSF grant DBI 055251, the Lee
Honors College, the Office of Vice President for Research (OVPR) Undergraduate Research
Excellence Award, and the College of Arts and Sciences Research and Creative Activities Award
at Western Michigan University.
Keywords: GDNF, Exercise, Skeletal Muscle
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Introduction
Skeletal muscles are the striated muscles in our body which act as the engine of the body.
They are used in everything from moving, eating, breathing, and standing still4. A skeletal muscle
is made up of many individual muscle fibers. These fibers contract as a result of the motor neuron
that innervates them. This connection occurs at the neuromuscular junction, which is defined as
where the nerve meets and innervates the muscle5. The neuromuscular junction is composed of the
motor neuron, the synaptic cleft, and the endplate on the muscle fiber. The synaptic cleft is a gap
between the membranes of the nerve cell and the muscle cell that spans about 50 nm wide. The end
plate is the region of the muscle fiber with which the terminals make contact4. In order for the
muscle contraction to occur, an action potential must travel down the axon of the motor neuron.
This electrical conduction causes the release of neurotransmitter, most importantly acetylcholine,
across the synaptic cleft. As the acetylcholine diffuses across the cleft and binds to the
acetylcholine receptors on the muscle cells, the muscle undergoes ionic changes which cause the
fibers, and the muscle as a whole, to contract.
Neurotrophic Factors are the functional group of growth factors that specialize in acting on
the cells of the nervous system. As the name indicates, these growth factors are considered trophic
agents, meaning they can only stimulate hypertrophic growth. This is due to the fact that the target
neuronal cells are post mitotic2. Some of the responses invoked by neurotrophic factors include
neurite proliferation, maintenance of viability, and induction of neural-specific genes.
Neurotrophic factors are divided into families of several homologous members. These members
have similar structure, amino acid sequences, and tissue specificity. Also, each family of
neurotrophic factors has a corresponding family of receptors of related proteins. There is a
growing body of research on the how neurotrophic factors impact the nervous system but there are
still gaps in our understanding of all the functions neurotrophic factors provide.
-3-

Glial cell line-derived neurotrophic factor (GDNF) was first discovered as a growth factor
that was secreted from glial cells, capable of supporting survival of dopaminergic neurons in the
embryonic ventral midbrain, and later the CNS1,13. Since its discovery, the known functions of
GDNF have increased significantly. Not only does GDNF promote the survival of additional
central neurons, but is thought to play a role in the survival of some peripheral ganglia as well,
such as spinal motor neurons1. Also, GDNF is not only found in a wide variety of neuronal tissues,
but also found in non-neuronal cells, such as skeletal muscle13.
In order to understand how GDNF affects the neuromuscular system, we must first know
where GDNF comes from and the exact target that it acts on. Although these issues are still
somewhat debated, there has been a lot of recent research done to find out more. We know that
GDNF can be synthesized by both the muscle cells and Schwann cells 6. However, regarding the
GDNF that localizes at the neuromuscular junction, many studies suggest that the neurotrophic
factor is secreted by the skeletal muscle. The GDNF is then taken up by the axon of the motor
neuron and transported to the cell body12,13.
At this point in time, the affects that GDNF has on the neuromuscular system seem
limitless. Originally, GDNF was thought to be specific for dopaminergic neuron growth3.
However, now it is known to have a variety of effects, including increasing muscle innervation at
the neuromuscular junction and neurotransmitter release. In one study on neonatal mice there was
significant increase in the number of innervating motor axons to a neuromuscular junction after
elevated GDNF levels in muscle cells6. Other studies have shown enhancement of
neurotransmitter release at immature mammalian neuromuscular synapses after increases in
GDNF7.
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Although the exact mechanism of action may be uncertain, there is no question that GDNF
is the most potent neurotrophic factor in the survival of motor neurons, both in vitro and in vivo3,6.
Research using GDNF knockout mice found a significant loss of motor neurons, showing that the
survival of motor neurons is dependent on GDNF1. Not only does GDNF rescue motor neurons
from naturally occurring cell death, but it can prevent the wasting away of motor neurons when
they are injured through axotomy3,13.
Knowing how beneficial GDNF is to the neuromuscular system, it is no surprise that
problems can arise with low levels of GDNF. These problems can occur with the usual aging and
inactivity that comes along with it, or with something more threatening, such as disease. It is
believed that GDNF is important in maintaining motor function with age, and the deficit of GDNF
can fast-track age-related motor problems. One study showed that motor function improved with
the administration of GDNF to aged rats13. Also, GDNF levels are crucial to maintaining
dopaminergic neurons during the aging process8. Just as dangerous as aging is inactivity, as GDNF
expression shows significant differences when inactive12.
The capabilities of GDNF cause researchers to believe that it could play a vital role in
fighting against the degeneration and death of motor neurons that come with neuromuscular
diseases such as amyotrophic lateral sclerosis (ALS) and Parkinson’s Disease (PD)3. PD is due to
the loss of dopamine neurotransmission. In a recent study, treating PD model rats with GDNF
injections resulted in significant reduction of motor deficits, as well as increases in dopaminergic
neurons9. ALS is caused by the death of large motor neurons in the brain and spinal cord,
potentially as a result of glial dysfunction. With ALS patients, GDNF is a successful therapeutic
measure in vitro, however it has not been able to be put to the test in vivo due to difficulties with
crossing the blood-brain barrier11.
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Although these outcomes of low GDNF can be frightening, research has shown that there
may potentially be ways to increase GDNF levels. One of the most promising methods is exercise,
as GDNF is believed to be produced in skeletal muscle6,10,13. It is well known that physical activity
can alter the neuromuscular junction, but it is still unknown how and if GDNF plays a role in these
alterations. However, research in Dr. Spitsbergen’s WMU lab has been convincing that GDNF has
a role due to the increases of GDNF we see with exercise. Not only do we see increases in GDNF
content in skeletal muscle, but have also been able to observe alterations in acetylcholine and
acetylcholine receptor activation12. In addition, we have seen increased size and degree of
branching of motor nerve terminals at the NMJ. Notably, differences in GDNF content were
observed based on the level of activity14. Forced wheel running increases GDNF levels in rats but
hind limb suspension decreases GDNF in the hind limb muscles12. These observations lead us to
believe that exercise could be used as a therapeutic measure against motor neuron deficiencies.

Hypothesis
Through my research I attempt to address a couple of important ideas for continuing the
research on the relationship between GDNF and exercise. The first goal of my study was to
determine whether our lab can use the same methods in mice as we used in rats. If this is true, we
can expand our research by using more genetic variations that are only available in mouse models.
Specifically, I will look at whether we can use the same enzyme-linked immunosorbant assay
(ELISA) method that has been used in rat models, to measure GDNF content in mouse muscle. I
will also explore if we can use the immunocytochemical staining methods previously described in
rat to visualize GDNF in mouse muscle. Related to this, I will confirm our prediction that exercise
increases GDNF content in mouse skeletal muscle, as we have seen occur in rat skeletal muscle.
Beyond this research, I will explore my own hypothesis about whether a tonically active skeletal
muscle, such as diaphragm, contains more GDNF protein than phasically active muscle, such as
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the pectoralis major. I predict that muscles showing higher levels of contractile activity will
produce higher levels of GDNF protein.
Methodology

I.

Subjects

Thirteen young adult mice of 3 months of age were used in this experiment. Treatment groups
include 7 control mice and 6 exercise mice that underwent walk training. The control group had no
access to a running wheel. The exercise group had a one-week training period, and then exercised
on the wheel for 30 minutes a day, at 8 meters/minute, five days a week. All animal experiments
were performed in accordance with the "Guide for the Care and Usage of Laboratory Animals"
(National Research Council) and all protocols have been approved by the Institutional Animal
Care and Usage Committee at Western Michigan University.

II.

Tissue Processing

After the last scheduled exercise session, mice were euthanized within 72 hours. Muscles from
one side of the mouse were removed, and used for GDNF protein quantification. Muscles were
removed and promptly dipped into liquid nitrogen. Tissues were then smashed into a fine powder
and mixed with sample processing buffer until homogenous. Samples were then centrifuged for 30
minutes at 4°C. The supernatant was stored at -80°C. The muscles from the other side of the mouse
were used in immunohistochemical staining. Muscles examined included the diaphragm (DIA), an
involuntary slow twitch muscle, and pectoralis major (PEC), a voluntary slow twitch muscle.

III.

GDNF Protein Quantification

Quantification of GDNF protein in skeletal muscle tissue was accomplished using an
enzyme-linked immunosorbant assay (ELISA). A 96-well plate was used to assess the GDNF
standard and the tissue supernatants. A standard curve was created from the known GDNF
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standard concentrations. Using this standard curve, the tissue samples could be analyzed for
GDNF protein content. These data values are expressed as pg GDNF/ mg Tissue Weight and
reported as a mean with a standard error of mean (SEM). The treatment groups are compared using
a t-test, with p values ≤ 0.05 considered statistically significant.

IV.

Immunocytochemistry

In order to localize GDNF in skeletal muscle samples, immunocytochemical staining was
used. Tissues were fixed overnight in 4% paraformaldehyde at 4°C then rinsed with phosphate
buffer saline (PBS). The pectoralis muscles were embedded in mounting medium and cut into 40
µm sections using a cryostat. These sections, as well as the already thin sections of diaphragm,
were then mounted on slides and vacuum sealed overnight. Primary antibodies were applied to the
slides and incubated overnight at 4°C. Then secondary antibodies conjugated with fluorescent
dyes were added for easy visualization. Rabbit anti GDNF (Santa Cruz Biotechnology, Santa
Cruz, CA) was bound to a secondary antibody conjugated to AlexaFluor 596 (Life Technologies)
in order to see GDNF and its location. α-Bungarotoxin was directly conjugated to AlexaFluor 488
(Life Technologies) to show the location of nicotinic acetylcholine receptors, which in turn
localizes the endplate of neuromuscular junctions. Mouse neurofilament was bound to a secondary
antibody conjugated to AlexaFluor 647 (Life Technologies) to view the axon of the motor neuron
making the neuromuscular junction with the muscle fiber. Tissues were then mounted onto the
slides using a 1:1 solution of PBS:glycerol and sealed with a cover slip. Slides were then
visualized using a Zeiss LSM 510 confocal laser scanning microscope and LSM510 software.
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Results

Exercise had no effect on GDNF content in the diaphragm.

FIG. 1 Results show that in tonically active diaphragm, there is no significant change in GDNF
protein content following 2 weeks of involuntary exercise. GDNF protein content of muscles was
measured via ELISA. Data represents the mean ± SEM from control and exercised groups. Control
animals averaged 8.685 pg GDNF/mg of tissue weight, while exercise animals averaged 7.217 pg
GDNF/mg of tissue weight, values that were not significantly different (p = 0.645).
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Exercise increases GDNF protein content in the pectoralis major.

FIG. 2 Results show that in phasically active pectoralis, there is a significant increase (p = 0.049)
in GDNF protein content following 2 weeks of involuntary exercise. GDNF protein content of
muscles was measured via ELISA. Data represents the mean ± SEM from control and exercised
groups. Control animals averaged 1.390 pg GDNF/mg of tissue weight, while exercise animals
averaged 6.655 pg GDNF/mg of tissue weight. The asterisk (*) denotes a significant difference
from control.
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GDNF staining is localized to the endplate region in muscle.

FIG. 3 Exercised diaphragm at 20x magnification. Sections were immunolabled using antibodies
against GDNF (blue), α-Bungarotoxin to identify acetylcholine receptors (endplate, green), and
antibodies against neurofilament to identify motor axons (red). GDNF is found in the same regions
as endplates. This supports the theory that GDNF is made in the muscle fiber and is expressed in
higher levels at the point where the nerve makes contact with the muscle.
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FIG. 4 Exercised pectoralis at high magnification. Sections were immunolabled using antibodies
against GDNF (blue), α-Bungarotoxin to identify acetylcholine receptors (endplate, green), and
antibodies against neurofilament to identify motor axons (red). There is positive staining for
GDNF in the region of the endplate. Once again this localization of GDNF suggests that the
protein is synthesized in the muscles around the neuromuscular endplate.
Discussion
Our results show that we were successful in using rat methods to measure GDNF in mice.
We can measure GDNF in mouse muscle using ELISA, allowing us to distinguish between tissues
with high v. low protein content. We can also detect GDNF in mouse muscle using
immunohistochemical methods. In using these methods, we are able to see correlations between
endplate and GDNF localization. Being able to use the same methods in mouse muscle that have
been previously used in rat muscle allows for expansion of research in several new directions.
Most importantly it will allow for the use of many genetic models that are available in mice.
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As previous studies have shown that exercise increases GDNF in rat muscles12, 13, my study
shows that exercise increases GDNF in mouse skeletal muscle as well, especially in a voluntary
muscle such as the pectoralis major. Although there was no increase in GDNF after exercise in the
diaphragm, this is not surprising since the muscle is involuntary, and continually in use while the
mouse is breathing. In the control animals, we can see that the involuntary diaphragm starts with
more GDNF than the voluntarily-used pectoralis major. Our results from the ELISA support our
hypothesis that tonically active diaphragm muscles produce more GDNF protein than phasically
active pectoralis major muscle. The results show that DIA from control animals contains more
GDNF than PEC.
However, after the exercise regimen, the treatment mice have a significant increase of
GDNF protein content in the pectoralis major, but not the diaphragm. Notably, the exercise brings
levels of GDNF in the pectoralis close to the control level of GDNF in the diaphragm. These
findings suggest that GDNF production is affected by exercise in voluntary slow-twitch muscles,
but not involuntary slow-twitch muscles. These results contribute to understanding the
mechanisms underlying the normal control of GDNF expression in skeletal muscles.
When looking at our results from immunohistochemical staining, we were successful in
seeing the endplate and localizing the GDNF around the endplate. This supports the theory that
GDNF is produced in the muscle and then shipped up the axon of the motor neuron. Although we
had good results for endplate and GDNF protein staining, our staining of the neurofilaments did
not produce good results. This could be due to many factors in our immunohistochemical staining
methods, however one likely explanation is that the antibody used to identify rat neurofilament
does not recognize mouse neurofilament.
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Recent studies have shown that GDNF is synthesized by the skeletal muscle cells, and
taken up by the neurons12,13. It is also believed that the GDNF synthesis may decrease due to the
cholinergic motor neurons regulating their own supply of GDNF, resulting in the inhibition of
excessive GDNF secretion from the muscle cells. The feedback loop providing the regulation of
GDNF production involves the ACh receptors on the muscle cells13. My observations of the
differences in the changes of GDNF content between pectoralis and diaphragm during an
increased exercise regime provides further support of a regulated GDNF system, one in which
increased neural/muscle activity increases GDNF content in muscle.
My staining shows GDNF localization around the endplates of the NMJ, supporting the
idea that GDNF is produced in the muscle around the NMJ. The increase in GDNF we observed in
the skeletal muscle of exercised mice could be due to an increase in muscle growth (hypertrophy).
Voluntary muscles, such as the pectoralis, have nearly unlimited growth potential, and exercise
would increases GDNF production in order to support the need for innervation of the growing
muscle. Once the muscle stops growing and is fully innervated the cholinergic neurons would start
regulating the production of GNDF through a mechanism involving the ACh receptors on the
skeletal muscles. My results support the regulated system hypothesis in that my exercised mice
had growing pectoralis muscles. Involuntary skeletal muscles, such as the diaphragm were under a
constant state of exercise in both the control group and the exercised group, and the difference in
growth of the diaphragm between the exercised mice and the control mice was not detectable in
GDNF production because the diaphragms of both groups of mice were already close to maximum
innervation due to their constant contractile activity. Therefore, the cholinergic motor neurons and
the ACh receptors on the muscle were already exhibiting equilibrium of GDNF secretion due to
constant activity.

- 14 -

Conclusion
It is important to develop a more complete understanding of normal expression of GDNF
in skeletal muscle before we can determine whether GDNF-based therapies may be used in the
treatment of traumatized or diseased neural tissues. The success of our mouse studies allows us to
expand our research into a variety of genetic models not available in rats. This expansion in
research will allow us to learn more about GDNF and neurotrophic factors. Through investigating
neurotrophic factors further, we can also expand our knowledge of neurons, glial cells,
neurotransmitters, and the electrical physiological properties of the nervous system.
Our observation that exercise increases GDNF in skeletal muscles may help explain the
beneficial effects of exercise on motor neurons. A better understanding of exercise’s effects on
GDNF production can aid the medical world with a preventative and possibly therapeutic measure
against fatal neuromuscular diseases, such as ALS, as well as typical aging. In continuing with this
GDNF research we hope to enhance the quality of life for those with neuromuscular deficits due to
motor neuron problems.
If given more time with this project, I would have liked to expand it in a couple different
ways. First, I would have explored deeper into the histology of the tissues using
immunohistochemical staining and analysis of factors such as GDNF localization in the
neurofilaments and endplate size. Using quantitative statistical analysis of these factors could tell
us more about both where GDNF is produced (muscle or neuron), as well as the effect that exercise
has on endplate size and synaptic strength. Also, I would have liked to use more tissues from the
mouse to confirm my hypothesis about the differences in GDNF production in involuntary v.
voluntary slow twitch muscles. Having more tissues that followed my hypothesis would make for
a stronger argument. I am anxious to see how GDNF research evolves in the future, as I believe it
could possibly be the answer to many neuromuscular deficits and disease.
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